The biopharmaceutical filtration market has been growing rapidly in recent years, driven by the increasing demand for biologics, as well as advances in filtration technologies.
It is a critical step in the manufacturing process of biopharmaceutical products, and its applications are essential in ensuring the safety, quality, and efficacy of the final product. The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:
- Type of Filtration System
- Depth Filtration System
- Tangential Flow Filtration Systems
- Membrane Filtration System
- Other Filtration Systems
- Type of Filter (based on use)
- Disposable / Single-use Filters
- Reusable / Multi-use Filters
- Type of Assembly
- Capsules
- Cartridges
- Others
- Type of Drug Product
- Antibodies
- Vaccines
- Recombinant Proteins
- Cell Therapies
- Gene Therapies
- Oligonucleotides
- Others
- Company Size
- Small / Mid-sized
- Large
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
The “Global Filtration Market (Focus on Biologics Manufacturing), 2023 – 2035” report features the following companies, which we identified to be key players in this domain:
- Asahi Kasei
- Cobetter Filtration
- Corning
- Merck
- Pall
- Parker Hannifin
- Sartorius
- Thermo Fisher Scientific
Table of Contents
- Preface
- Executive Summary
- Introduction
- Biopharmaceutical Filtration: Market Landscape
- Company Competitiveness Analysis
- Suppliers Headquartered in North America: Company Profiles
- Suppliers Headquartered in Europe and Asia-Pacific: Company Profiles
- Recent Developments
- Global Events Analysis
- Biopharmaceutical Filtration: Market Forecast and Opportunity Analysis
- Conclusion
- Executive Insights
- Appendix 1: Tabulated Data
- Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/global-filtration-market.html
Learn from experts: do you know about these emerging industry trends?
TCR Therapies: An Emerging Therapeutic Modality
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Comments (0)